Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Change in Acquisitions & Divestments (2019 - 2021)

CNBX Pharmaceuticals (CNBX) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $645968.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Change in Acquisitions & Divestments rose 178.31% year-over-year to $645968.0, compared with a TTM value of $645968.0 through Nov 2021, changed N/A, and an annual FY2023 reading of $24702.0, changed N/A over the prior year.
  • Change in Acquisitions & Divestments was $645968.0 for Q1 2021 at CNBX Pharmaceuticals, up from -$824849.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $824849.0 in Q4 2019 and bottomed at -$824849.0 in Q1 2020.
  • Average Change in Acquisitions & Divestments over 3 years is $215322.7, with a median of $645968.0 recorded in 2021.
  • Peak annual rise in Change in Acquisitions & Divestments hit 178.31% in 2021, while the deepest fall reached 178.31% in 2021.
  • Year by year, Change in Acquisitions & Divestments stood at $824849.0 in 2019, then tumbled by 200.0% to -$824849.0 in 2020, then skyrocketed by 178.31% to $645968.0 in 2021.
  • Business Quant data shows Change in Acquisitions & Divestments for CNBX at $645968.0 in Q1 2021, -$824849.0 in Q1 2020, and $824849.0 in Q4 2019.